Commercial Access Only
Specimen SS-COM-AST-0313 // ASTRINGENCY
Grape Extract T1-PR-IN
Vitis vinifera
Grape
Grape Extract SeriesTier 1
Target Trait
200
mg/L
Reported target: 200 mg/L proanthocyanidin
Technical Specifications
Genomic Edits
5
GC Content
(45%)
Construct Length
5,325 bp
Promoter System
Ubiquitin / T7
Expression System
Protoplast PEG-fusion
Host Strain
PEG-mediated
Pathway Edits
- LAR overexpression
- Leucoanthocyanidin reductase flux
Key Interventions
Single LAR cassette insertionBasal leucoanthocyanidin reductase activity
Application Domains
Industrial
Intended Use
High-purity grape tannin extract for pharmaceutical-grade astringency compounds — Industrial grade via protoplast peg-fusion.
Access
Request Commercial Access
This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.
Contact Us →No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.